Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma. Oncol Lett. 2024 Jun 21;28(2):388.
Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab. Eur Radiol. 2024 Jul 30.
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma. Clin Cancer Res. 2024 Jul 1;30(13):2812-2821
Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis. Liver Transpl. 2024 Apr 17
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study. Front Oncol. 2024 Feb 28;14
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC. Hepatology. 2024 Feb 15.
Induction of liver transplant immune tolerance in an outbred rat strain model using tacrolimus. Lab Anim Res. 2023 Mar 8;39(1):5.
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation. Int J Mol Sci. 2023 Mar 5;24(5):5002.
1Intrahepatic infiltration of activated CD8+ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury. Front Immunol. 2023 Mar 1;14
Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures. Transplantation. 2022 Oct 1;106(10):1990-1999.
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2022 Sep;77(3):632-641.
Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients. Front Immunol. 2022 Mar 28;13:817006.
A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients. Gut Microbes. 2022 Jan-Dec;14(1):2102885.
FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance. J Transl Med. 2022 Feb 25;20(1):104.